People: Anavex Life Sciences Corp (AVXL.OQ)

AVXL.OQ on NASDAQ Stock Exchange Capital Market

1:30am IST
Change (% chg)

$0.03 (+1.18%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Missling, Christopher 

Dr. Christopher U. Missling, Ph.D., is President, Chief Executive Officer, Secretary, Director of Anavex Life Science Corp. He was Chief Financial Officer Anavex Life Sciences Corp. Christopher Missling has over twenty (20) years of healthcare industry experience in big pharmaceutical, biotech industry and investment banking. Most recently, from March 2007 until his appointment by our company, Mr. Missling served as the head of healthcare investment banking at Brimberg & Co. in New York, New York. Also, Mr. Missling served as the Chief Financial Officer of Curis, Inc. (NASDAQ:CRIS) and ImmunoGen, Inc. (NASDAQ:IMGN). Mr. Missling earned his M.S. and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management.

Basic Compensation

Total Annual Compensation, USD 305,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 10,786,200
Fiscal Year Total, USD 11,091,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --